Cargando…

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study

BACKGROUND: Anti-CD20 therapies induce pronounced B-cell depletion and blunt humoral responses to vaccines. Recovery kinetics of anti-CD20 therapy-mediated cellular and humoral effects in people with multiple sclerosis (pwMS) are poorly defined. OBJECTIVE: To investigate the duration of the anti-CD2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moser, Tobias, O’Sullivan, Ciara, Otto, Ferdinand, Hitzl, Wolfgang, Pilz, Georg, Schwenker, Kerstin, Mrazek, Cornelia, Haschke-Becher, Elisabeth, Trinka, Eugen, Wipfler, Peter, Harrer, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Neurology in the Time of COVID-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036387/ https://www.ncbi.nlm.nih.gov/pubmed/35479655 http://dx.doi.org/10.1177/17562864221092092

Ejemplares similares

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy
por: Moser, Tobias, et al.
Publicado: (2021)

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
por: Harrer, Christine, et al.
Publicado: (2021)

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study
por: Pilz, Georg, et al.
Publicado: (2019)

Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study
por: Moser, Tobias, et al.
Publicado: (2022)

Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
por: Pilz, Georg, et al.
Publicado: (2020)

Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis
por: Harrer, Andrea, et al.
Publicado: (2012)

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod
por: Harrer, Andrea, et al.
Publicado: (2015)

Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
por: Capuano, Rocco, et al.
Publicado: (2021)

Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients
por: Moser, Tobias, et al.
Publicado: (2021)

Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
por: Feige, Julia, et al.
Publicado: (2022)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders—A Pilot Study
por: Foettinger, Fabian, et al.
Publicado: (2023)

Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities
por: Otto, Ferdinand, et al.
Publicado: (2021)

The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation
por: Harrer, Christine, et al.
Publicado: (2022)

Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events
por: O´Sullivan, C., et al.
Publicado: (2021)

Oropharyngeal swab for SARS-CoV-2 test causing atypical internal carotid artery dissection and stroke in a patient after mild COVID-19
por: Asan, Livia, et al.
Publicado: (2021)

Anti-GFAP-antibody positive postinfectious acute cerebellar ataxia and myoclonus after COVID-19: a case report
por: Asan, Livia, et al.
Publicado: (2021)

Covid-vaccine-fear-induced paroxysmal atrial fibrillation causing multiple acute arterial infarctions: a case report
por: Theodorou, Aikaterini, et al.
Publicado: (2022)

MOG antibody–associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report
por: Escolà, Jordi Kühne, et al.
Publicado: (2022)

Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response
por: Hirzel, Cédric, et al.
Publicado: (2022)

Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients
por: Fragkou, Paraskevi C., et al.
Publicado: (2022)

Mid-term MRI evaluation reveals microstructural white matter alterations in COVID-19 fully recovered subjects with anosmia presentation
por: Pelizzari, Laura, et al.
Publicado: (2022)

Comment on ‘MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report’
por: Finsterer, Josef, et al.
Publicado: (2022)

Immunologic resilience and COVID-19 survival advantage
por: Lee, Grace C., et al.
Publicado: (2021)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals
por: Li, Min, et al.
Publicado: (2022)

Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China
por: Chen, Ruchong, et al.
Publicado: (2020)

Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting
por: Seiberl, Michael, et al.
Publicado: (2023)

HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
por: Gigli, Gian Luigi, et al.
Publicado: (2020)

Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
por: Abolhassani, Hassan, et al.
Publicado: (2022)

Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers
por: Krüttgen, Alexander, et al.
Publicado: (2022)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

The immunologic status of newborns born to SARS-CoV-2–infected mothers in Wuhan, China
por: Liu, Pin, et al.
Publicado: (2020)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort
por: Simon, David, et al.
Publicado: (2022)

Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
por: Hou, Hongyan, et al.
Publicado: (2021)

SG-APSIC1054: Sputnik-V postvaccination immunologic responses in nasal mucosa: A prospective cohort study in Kazakhstan
por: Kadyrova, Irina, et al.
Publicado: (2023)

Tick-Borne Encephalitis Virus RNA Found in Frozen Goat’s Milk in a Family Outbreak
por: Mylonaki, Eirini, et al.
Publicado: (2022)

Sixty-day consequences of COVID-19 in patients discharged from hospital: an electronic health records study
por: Islam, Nazrul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v2t13p5n0kd7q5tmogdelkcnfj